BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2254114)

  • 1. Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer.
    Arriagada R; Mouriesse H; Spielmann M; Mezlini A; Oudinot P; le Chevalier T; Cuvier C; Fontaine F; Travagli JP; May-Levin F
    Int J Radiat Oncol Biol Phys; 1990 Nov; 19(5):1207-10. PubMed ID: 2254114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
    Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
    Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer].
    Hasbini A; Le Péchoux C; Roche B; Pignol JP; Zelek L; Abdulkarim B; Arriagada R; Guinebretière JM; Tardivon A; Spielmann M; Habrand JL
    Cancer Radiother; 2000; 4(4):265-73. PubMed ID: 10994390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group.
    Arriagada R; le Chevalier T; Ruffie P; Baldeyrou P; De Cremoux H; Martin M; Chomy P; Cerrina ML; Pellae-Cosset B; Tarayre M
    Int J Radiat Oncol Biol Phys; 1990 Nov; 19(5):1135-8. PubMed ID: 2174838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
    Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B.
    Marks LB; Halperin EC; Prosnitz LR; Ross M; Vredenburgh JJ; Rosner GL; Peters W
    Int J Radiat Oncol Biol Phys; 1992; 23(5):1021-6. PubMed ID: 1639635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases.
    Pergolizzi S; Adamo V; Russi E; Santacaterina A; Maisano R; Numico G; Palazzolo C; Ferraù F; Settineri N; Altavilla G; Girlando A; Spadaro P; Cascinu S
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):25-32. PubMed ID: 16446058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
    Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies in inflammatory breast carcinoma based on prognostic factors.
    Rouëssé J; Friedman S; Mouriesse H; Sarrazin D; Spielmann M
    Breast Cancer Res Treat; 1990 Jul; 16(1):15-22. PubMed ID: 2207344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
    Sataloff DM; Mason BA; Prestipino AJ; Seinige UL; Lieber CP; Baloch Z
    J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
    Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
    Stemmer SM; Pfeffer MR; Rizel S; Hardan I; Goffman J; Gezin A; Neumann A; Kitsios P; Alezra D; Brenner HJ
    Cancer; 2001 Jun; 91(11):1983-91. PubMed ID: 11391576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
    Ung O; Langlands AO; Barraclough B; Boyages J
    J Clin Oncol; 1995 Feb; 13(2):435-43. PubMed ID: 7844606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
    Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
    Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.
    Bourgier C; Pessoa EL; Dunant A; Heymann S; Spielmann M; Uzan C; Mathieu MC; Arriagada R; Marsiglia H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):690-5. PubMed ID: 21277101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year outcome after combined modality therapy for inflammatory breast cancer.
    Harris EE; Schultz D; Bertsch H; Fox K; Glick J; Solin LJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1200-8. PubMed ID: 12654428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast cancers, apparently non-metastatic, treated by prior chemotherapy and radiotherapy, combined with or without excision surgery. Preliminary results].
    Touboul E; Lefranc JP; Blondon J; Guerin RA
    Bull Cancer; 1988; 75(6):523-31. PubMed ID: 2843249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.